Dechra Veterinary Products has extended the licence on its popular infectious bronchitis vaccine, Avishield IB G1-13, which is now available for laying hens and breeding chicks throughout the production period.
The first vaccine in the range to be approved for use in laying hens and breeding chicks, Avishield IB G1-13 is indicated for active immunisation of chicks to reduce the adverse effect on cilia caused by infectious bronchitis.
The vaccine is one of two targeting the IBV 793B serotype and, with the addition of this new claim, Avishield can now be administrated on broiler, broiler breeder and laying hen farms.
Avishield IB GI-13 is a lyophilisate for oculonasal suspension/use in drinking water which contains live avian infectious bronchitis virus variant strain V-173/11: 102.7-104.6 EID50.
It has an onset of immunity 10 days after vaccination and a duration of immunity of 56 days.
Johnny Wells West, poultry key account manager at Dechra Veterinary Products, comments: “The new licence extension for Avishield IB G1-13 allows greater flexibility for poultry producers to protect their flocks against infectious bronchitis on broiler, broiler breeder and laying hen farms and it is welcome news for both Dechra and the poultry industry.”
Dechra’s Avishield poultry vaccine range consists of evolved vaccines for protection against infectious bronchitis, Gumboro and Newcastle disease.
All vaccines are regulated for use in broilers, future layers and future breeders.
For more information on Avishield IB G1-13 or the Avishield range please contact Johnny Wells West on 07584 175758 or visit the website.
